Lanean...
Haplo is the new black
In this edition of Blood, Bertaina et al report 3-year survival exceeding 90% by using haploidentical αβ(+)CD3(+)/CD19(+)-depleted allogeneic transplantation for children with nonmalignant disorders.(1)
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Society of Hematology
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4118482/ https://ncbi.nlm.nih.gov/pubmed/25082865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-06-579714 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|